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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S146there was any dysregulation of expression in cartilage from patients with
osteoarthritis.
Methods and Results:We looked for expression of nucleostemin mRNA in
cartilage, bone and synovial tissue by RT-PCR and this conﬁrmed expres-
sion of full length transcripts from all three tissues. Further studies using
western blotting showed that nucleostemin was expressed in cultured
articular chondrocytes and that expression levels (corrected for GAPDH)
were slightly higher in chondrocytes cultured from OA cartilage (n¼5)
versus those cultured from normal cartilage (n¼4) (0.900.12 vs.
0.590.11) although the differences were not signiﬁcant (p¼0.12). Nucle-
ostemin protein was also detected by western blotting in fresh extracts of
articular cartilage. Analysis of fresh and cultured articular chondrocytes by
immunohistochemistry showed evidence of nucleostemin expression
localised to the nucleoli.
Conclusions: We conclude that nucleostemin is expressed within several
articular tissues including chondrocytes where it is localised within the
nucleoli. Although we found that levels of protein expressionwere slightly
raised in osteoarthritic chondrocytes as compared with normal chon-
drocytes, the number of samples studied was small and this will have to be
conﬁrmed by further research.
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DELPHINIDIN BLOCKS IL-1b-INDUCED ACTIVATION OF NF-kB BY
MODULATING THE IKKb GENE EXPRESSION AND THE ACTIVATION OF
NIK IN HUMAN CHONDROCYTES
A. Haseeb, D. Chen, T.M. Haqqi. MetroHlth. Med. Ctr./CWRU, Cleveland, OH,
USA
Purpose: Osteoarthritis (OA) is a highly prevalent disease that affects the
quality of life of its victims. Interleukin-1 b (IL-1b) plays a major role in the
pathogenesis of OA and is present in the arthritic joints at high levels. IL-1b
has been shown to cause increased production of catabolic enzymes such
as MMPs, and inﬂammatory mediators such as prostaglandins and nitric
oxide through the activation of several signaling pathways including NF-
kB. Novel approaches using plant derived polyphenols to inhibit signal
transduction pathways have shown promise and could overcome some of
the toxicity issues related to current therapies. One key signaling mecha-
nism implicated in OA that could be a target of orally bioavailable inhibi-
tors is the NF-kB pathway. Delphinidin (2-(3,4,5-trihydroxyphenyl)
chromenylium-3,5,7-triol) is an anthocyanidin that is widely distributed in
pigmented fruits and ﬂowers and has been shown to possess anti-
inﬂammatory activity and block the activation of NF-kB in cancer cells. No
such study with human chondrocytes has been reported. In the present
study using primary human chondrocytes we determined (a) the chon-
droprotective effect of Delphinidin; and (b) mechanism of NF-kB inhibition
in IL-1b-stimulated human chondrocytes.
Methods: Chondrocytes were derived by enzymatic digestion of human
cartilage (OA chondrocytes) from patients undergoing total knee arthro-
plasty. OA chondrocytes were pretreated with Delphinidin for different
time points and were then stimulated with IL-1b (10ng/ml) in vitro and
total RNA or cell lysate was prepared following our standard protocols. To
determine the gene expression, single stranded cDNAwas synthesized and
the expression of target mRNAs (COX-2, MMP-13, iNOS) was quantiﬁed
using TaqMan Assays. HeLa cells were transfected with promoter reporter
vectors and negative control vectors using the Fugene-6 reagent and the
effect on promoter activity was veriﬁed by Luciferase assay. Activation of
NF-kB p65 was determined by speciﬁc ELISA-based DNA binding assay.
Total protein levels were determined by detergent compatible Biorad
Protein Assay. Nitric oxide production was determined by Griess reaction.
Protein expression and the phosphorylated forms of different kinases were
determined byWestern immunoblotting. Data were analyzed using Origin
6.1 software package and p<0.05 was considered signiﬁcant.
Results: Pretreatment of chondrocytes with Delphinidin (50 mg/ml) for 2
hrs signiﬁcantly inhibited the IL-1b induced expression of COX-2, iNOS and
MMP-13 and the production of nitric oxide. Delphinidin also inhibited the
phosphorylation of IKKb and was also a potent suppressor of IKKb gene
and protein expression in OA chondrocytes. IKK promoter had a strong
activity in HeLa cells and this activity and production of the Luciferase
reporter enzyme was blocked by pre-treatment with Delphinidin. Func-
tional pathway analyses showed that IL-1b-induced phosphorylation ofNF-kB-inducing Kinase (NIK), which interacts with and activates IKKa and
IKKb which then phosphorylate IkB, was inhibited by pretreatment of OA
chondrocytes with Delphinidin. In agreement with these ﬁndings, pre-
treatment with Delphinidin inhibited the phosphorylation and degrada-
tion of IkB, as determined by Western immunoblotting, and the activation
and the DNA binding activity of NF-kB p65 determined by a highly speciﬁc
ELISA based assay.
Conclusions: Taken together, the data presented here identiﬁes a novel
mechanism of NF-kB inhibition by Delphinidin by inhibiting NIK, a kinase
upstream of IKK complex in the NF-kB activation pathway. Given the
important role played by IL-1b and NF-kB in OA, these results may provide
important clues to develop useful pharmacological inhibitors of NF-kB for
the prevention and/or treatment of OA.
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REDIFFERENTIATION OF HUMAN ARTICULAR CHONDROCYTES IN 2D
VERSUS 3D CULTURE
M.J. Caron, P.J. Emans, L. Voss, D.A. Surtel, M.M. Coolsen, L.W. van Rhijn,
T.J. Welting. Dept. Orthopaedic Surgery, Maastricht Univ. Med. Ctr.,
Maastricht, NETHERLANDS
Purpose: For cartilage regenerative techniques human articular chon-
drocytes (HACs) are cultured in vitro. Unfortunately, long expansion time
and multiple passaging lead to ‘dedifferentiation’. To overcome dediffer-
entiation, chondrocytes are ‘redifferentiated’ in 3D-culturemodels (pellets,
alginate cultures etc.). However, 2D (monolayer) culture methods are less
laborious and have better reproducibility. We therefore set out to compare
redifferentiation characteristics of HACs in 2D and 3D systems
Methods: HACs were expanded in monolayer from 15 independent
donors. Redifferenitiation in monolayer was performed at subconﬂuency.
Identical medium conditions were used to redifferentiate cells in pellets or
alginate beads. After 7 days chondrogenic marker-expression was
analyzed.
Results:Monolayer redifferentiation did not support expression of Col2a1
and Sox9 mRNAs, whereas chondrocyte hypertrophy markers Col10A1,
Runx2 and ALP were signiﬁcantly increased. Col2a1 and Sox9 mRNA
expression in HACs redifferentiated in pellets or alginate beads increased
signiﬁcantly, as did Col10a1 and RunX2. Suggesting that redifferentiation
in monolayer does not fully support a chondrogenic phenotype. However,
when corresponding protein samples were analyzed we detected
a profound upregulation of Col2A1 and Sox9 protein expression in
monolayer samples which was quantitatively equal to samples from 3D
cultures. Upregulation of RunX2 and Col10A1 protein expression was also
found in both culture systems, with the monolayer cultures inducing these
markers to higher levels than 3D cultures.
Conclusions: For the ﬁrst time redifferentiation capacity of HACs was
compared between 2D and 3D culture techniques by gene expression as
well as by protein expression. Although gene expression analyses indicate
that monolayer does not support chondrogenic redifferentiation, protein
expression analysis proved the opposite. Besides a fundamentally inter-
esting contradictory observation, our data show that redifferentiation of
HACs is possible in monolayer but behaves differently on the gene
expression as compared to 3D culture systems. Monolayer provides
a reproducible and low cell amount-demanding culturesystem better
suited for molecular and genetic interference studies into chondrocyte
biology.
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IMPAIRMENT OF MITOCHONDRIAL 8-OXOGUANINE DNA GLYCOSYLASE
(OGG1) AGAINST ACCUMULATION OF 8-OXOGUANINE IN
OSTEOARTIRITIC CHONDROCYTES.
K. Yudoh, R. Karasawa. St. Marianna Univ. Sch. of Med., Kawasaki City, Japan
Purpose: It is well known that chondrocytes produce excess amounts of
reactive oxygen species (ROS) as well as proinﬂammatory cytokines and
chemokines in response to mechanical and chemical stresses. An oxidized
form of guanine, 8-oxo-7,8-dihydroxyguanine (8-oxoguanine) is a major
causative lesion for mutagenesis by ROS, since it can form a stable base pair
with adenine as well as with cytosine during DNA replication. 8-
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S147oxoguanine DNA glycosylase (Ogg1) repairs the 8-oxoguanine, one of the
most abundant DNA adducts caused by oxygen free radicals. This study
identiﬁed mitochondrial Ogg1 as a pathogenic mechanism in response to
catabolic factors in osteoarthritis (OA).
Methods: 8-oxoguanine and Ogg1 expressions were investigated in
human OA cartilage and rat OA cartilage by immunohistologic analysis. We
studied whether OA-related catabolic factors inﬂuence expression of Ogg1
or 8-oxoguanine in OA chondrocytes and analyzed the relationship among
cellular function, apoptosis and Ogg1 or 8oxoguanine expression in human
chondrocytes.
Results: We observed the increased level of 8-oxoguanine and the
decreased level of Ogg1 in OA chondrocytes in comparison with normal
chondrocytes in OA rats as well as in patients with OA. OA-related catabolic
factors induced the overexpression of 8-oxoguanine and down-regulation
of Ogg1 in chondrocytes. We found that overexpression of mitochondria
Ogg1 in OA chondrocytes prevents catabolic stress-induced mitochondrial
dysfunction, caspase-9 activation and apoptosis in vitro. Furthermore,
Ogg1 silencing using siRNA reduced chondrocyte activity and augments
apoptosis in OA chondrocytes.
Conclusions: The accumulation of an oxidized form of guanine, 8-oxo-
guanine, and down-regulation of its repair enzyme Ogg1 in OA chon-
drocytes may be involved in the pathogenesis of OA. Our study suggests
that Ogg1 prevents catabolic stress-mediated chondrocyte dysfunction
and apoptosis that might be associated with the maintenance of articular
cartilage.
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PHYSIOLOGICAL CONCENTRATIONS OF GLUCOSAMINE SULFATE AND
GLUCOSAMINE HCL CAN DOWNREGULATE INTERLEUKIN-1, KININS
AND MMPS IN HUMAN OSTEOARTHRITIC CHONDROCYTES
W. Wu, M. Pasierb. Henry Ford Hosp., Detroit, MI, USA
Purpose: Glucosamine (GLN) products are taken by patients suffering
fromOA and other joint problems. In the United States it sold in the form of
Glucosamine HCL (GHCl) as a nutritional supplement, while in Europe it is
prescribed in the Glucosamine Sulfate (GS) form. In clinical trials both in
the US and Europe has shown that GLN can reduce pain scores in patients
with moderate to severe knee pain. Although GLN may be beneﬁcial, their
exact mechanism of action(s) remains obscure. Also because of the two
different forms used, there is still controversy to which form of GLN is
more effective. To further elucidate their mechanism of action, we deter-
mined the effects of both forms GLN at concentrations attainable in vivo
and lower than those reported in in vitro studies, on selected pain medi-
ators, inﬂammatory mediators, collagenases MMP-1 and MMP-13 using
cytokine-stimulated human chondrocyte cultures.
Methods: We took advantage of the recent pharmacokinetic information
of GLN concentrations in plasma and synovial ﬂuid to conduct our studies.
Human (n¼3) OA chondrocytes (ages: 53, 59 & 62) were isolated from
cartilage obtained from total knee arthroplasty. Chondrocytes were seeded
at 0.5 X 106 cells/ml and cultured in the presence of DMEM plus 10% FBS for
48h. Pharmaceutical grade GS and GHCl were provided as kind gifts from
Bioiberica, SA, Spain. The chondrocytes were then serum starved for 24h
and treated with either of the following: Control (Ctrl), 5 ng/ml human
recombinant IL-b (IL-1), 0.5mg/ml GS, 5.0mg/ml GS, 0.5mg/ml GHCl, 5.0mg/
ml GHCl, IL-1 + 0.5mg/ml GS, IL-1 + 5.0 mg/ml GS, IL-1 + 0.5mg/ml GHCl or IL-
1 + 5.0 mg/ml GHCl. Cells and media were collected 48h after stimulation.
Total RNA was isolated from cells. Semi-quantative RT-PCR was uses to
assess gene expression for Kininogen, IL-1b, IL-1b receptor, MMP-1 and
MMP-13. Proteins of MMP-1 and MMP-13 secreted into the media were
measured by Western blot. Gene and Western blot data were analyzed
statistically using the student t-test. Different letters within a parameter
indicate signiﬁcant differences (P <0.05) differences between treatments.
Results: As expected, the addition of 5ng/ml of IL-1b stimulated the mRNA
expression of IL-1b, IL-1 receptor, Kininogen, MMP-1 and MMP-13 in the
OA chondrocytes. Chondrocytes cultured in the preseence of 0.5GS, 5.0 GS,
0.5 GHCl and 5.0 GHCl were all able to down-regulate the mRNA expres-
sion of these genes signiﬁcantly. In most cases, both the GS and GHCl were
able to repress expression to or below control levels. Western blotting of
MMP-1 and MMP-13 conﬁrmed gene expression data at the protein level.
Both GS and GHCl decreased the protein abundance of cytokine stimulatedMMP-1 and MMP-13. The addition of GS showed more potency as
compared to GHCl at the same concentrations in suppressing the gene
expression of these mediators.
Conclusions: The most common symptom and complaint of OA patients
is joint pain which often increases in severity until the only clinical
option is total joint arthroplasty. Despite the central position of pain in
the progression and management of OA, little is known about the causes
of OA pain. Pain receptors are present in cartilage but the functional
signiﬁcance of their presence is not known. A possibility may be the
generation of soluble pain mediators that migrate to adjacent tissues to
elicit an effect. Pain mediators in cartilage may also play a role in cartilage
degradation. Low grade inﬂammation occurs in OA resulting in joint pain.
The addition of both forms of GLN was effective in depressing expression
of Kininogen, IL-1b and its receptor. This would indicate that GLN can
downregulate inﬂammatory effects such as further inﬂammation, pain
and cartilage matrix turnover. The concentration of GLN at 0.5mg/ml is
about 6 times lower than that found in human serum after GLN ingestion.
More studies that investigate the signaling cascade involved in this
regulation of pain mediators, inﬂammatory cytokines and MMPs will
allow us to understand the molecular action of GLN in OA pain and as
a treatment for OA.
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MIMICKING THE RESPIRATORY BURST MYELOPEROXIDASE SYSTEM OF
POLYMORPHONUCLEAR NEUTROPHIL GRANULOCYTES TO AID THE
WOUND HEALING BEHAVIORS OF ARTICULAR CARTILAGE
W.K. Augé, II. NuOrtho Surgical, Inc., Fall River, MA, USA
Purpose: Articular cartilage exhibits a limited ability to remove damaged
tissue from its surfaces, a step integral for efﬁcient mammalian wound
healing that is typically enabled by polymorphonuclear neutrophil gran-
ulocytes in other tissue types. This limited ability constrains articular
cartilage wound healing behaviors, contributing to lesion progression and
the disease burden of osteoarthritis. The respiratory burst myeloperox-
idase system of polymorphonuclear neutrophil granulocytes produces low
stability protonating agents involved in exothermic tissue homeostasis and
repair mechanisms through disproportionation redox reactions. Because
these protonating agents facilitate the removal of damaged interstitial
matrices through biopolymer disaggregation in order to assist differenti-
ated tissue assembly activities, this study evaluates the capability of
alternating current redoxmagnetohydrodynamic technology tomimic this
respiratory burst to aid the wound healing behaviors of articular cartilage
by creating a healthy lesion site devoid of damaged tissue.
Methods: An alternating current redox magnetohydrodynamic device
fashioned as a physiochemical scalpel was deployed in 0.9% sodium
chloride solutions at 300 mOsm/L and at 20oC. Figure 1 demonstrates the
device producing solution changes that are delivered to tissue surfaces as
